Finch Therapeutics Group, Inc. (FNCHQ)
OTCMKTS · Delayed Price · Currency is USD
9.97
-0.03 (-0.30%)
Jul 27, 2026, 9:30 AM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $16.01 million as of July 28, 2026. Its market cap has decreased by -20.56% in one year.
Market Cap
16.01M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$9.97
ChartMarket Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 16.01M, a decrease of -98.41%. That is a compound annual growth rate of -53.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 16.01M | -26.08% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EOM Pharmaceuticals Holdings | 26.41M |
| Provectus Biopharmaceuticals | 26.10M |
| BetterLife Pharma | 23.88M |
| ZIVO Bioscience | 20.76M |
| Galera Therapeutics | 18.20M |
| Oncotelic Therapeutics | 15.96M |
| Inhibitor Therapeutics | 15.07M |
| Zeo ScientifiX | 12.93M |